BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23644648)

  • 1. Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates.
    Trittmann JK; Nelin LD; Klebanoff MA
    Eur J Pediatr; 2013 Sep; 172(9):1173-80. PubMed ID: 23644648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopmental outcomes of extremely low-gestational-age neonates with low-grade periventricular-intraventricular hemorrhage.
    Payne AH; Hintz SR; Hibbs AM; Walsh MC; Vohr BR; Bann CM; Wilson-Costello DE;
    JAMA Pediatr; 2013 May; 167(5):451-9. PubMed ID: 23460139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated with Neurodevelopmental Impairment in Bronchopulmonary Dysplasia.
    Bauer SE; Schneider L; Lynch SK; Malleske DT; Shepherd EG; Nelin LD
    J Pediatr; 2020 Mar; 218():22-27.e2. PubMed ID: 31926665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of developmental outcomes in a very preterm Canadian cohort.
    Synnes A; Luu TM; Moddemann D; Church P; Lee D; Vincer M; Ballantyne M; Majnemer A; Creighton D; Yang J; Sauve R; Saigal S; Shah P; Lee SK;
    Arch Dis Child Fetal Neonatal Ed; 2017 May; 102(3):F235-F234. PubMed ID: 27758929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants.
    Bolisetty S; Dhawan A; Abdel-Latif M; Bajuk B; Stack J; Lui K;
    Pediatrics; 2014 Jan; 133(1):55-62. PubMed ID: 24379238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Need for supplemental oxygen at discharge in infants with bronchopulmonary dysplasia is not associated with worse neurodevelopmental outcomes at 3 years corrected age.
    Lodha A; Sauvé R; Bhandari V; Tang S; Christianson H; Bhandari A; Amin H; Singhal N
    PLoS One; 2014; 9(3):e90843. PubMed ID: 24646665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental Outcomes of Preterm Infants Born <29 Weeks with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Multicenter Study.
    Thomas SR; Jain SK; Murthy P; Joseph CJ; Soraisham A; Tang S; Dosani A; Lodha A
    Am J Perinatol; 2024 May; 41(S 01):e2505-e2513. PubMed ID: 37399847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental outcomes of premature infants with severe intraventricular hemorrhage.
    Calisici E; Eras Z; Oncel MY; Oguz SS; Gokce İK; Dilmen U
    J Matern Fetal Neonatal Med; 2015; 28(17):2115-20. PubMed ID: 25354288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of Bronchopulmonary Dysplasia and Neurodevelopmental Outcome at 2 and 5 Years Corrected Age.
    Katz TA; Vliegenthart RJS; Aarnoudse-Moens CSH; Leemhuis AG; Beuger S; Blok GJ; van Brakel MJM; van den Heuvel MEN; van Kempen AAMW; Lutterman C; Rijpert M; Schiering IA; Ran NC; Visser F; Wilms J; van Kaam AH; Onland W
    J Pediatr; 2022 Apr; 243():40-46.e2. PubMed ID: 34929243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental Impairment Among Extremely Preterm Infants in the Neonatal Research Network.
    Adams-Chapman I; Heyne RJ; DeMauro SB; Duncan AF; Hintz SR; Pappas A; Vohr BR; McDonald SA; Das A; Newman JE; Higgins RD;
    Pediatrics; 2018 May; 141(5):. PubMed ID: 29666163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the Definition of Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory Support for Preterm Neonates.
    Isayama T; Lee SK; Yang J; Lee D; Daspal S; Dunn M; Shah PS;
    JAMA Pediatr; 2017 Mar; 171(3):271-279. PubMed ID: 28114678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental and Behavioral Outcomes in Extremely Premature Neonates With Ventriculomegaly in the Absence of Periventricular-Intraventricular Hemorrhage.
    Pappas A; Adams-Chapman I; Shankaran S; McDonald SA; Stoll BJ; Laptook AR; Carlo WA; Van Meurs KP; Hintz SR; Carlson MD; Brumbaugh JE; Walsh MC; Wyckoff MH; Das A; Higgins RD;
    JAMA Pediatr; 2018 Jan; 172(1):32-42. PubMed ID: 29181530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study.
    Nakanishi H; Uchiyama A; Kusuda S
    J Perinatol; 2016 Oct; 36(10):890-6. PubMed ID: 27442157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with neurodevelopmental impairment in preterm infants with bronchopulmonary dysplasia.
    Yazici A; Buyuktiryaki M; Simsek GK; Kanmaz Kutman HG; Canpolat FE
    Eur Rev Med Pharmacol Sci; 2022 Mar; 26(5):1579-1585. PubMed ID: 35302203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of inpatient polysomnogram characteristics and discharge outcomes in infants with bronchopulmonary dysplasia requiring home oxygen therapy.
    Flores-Fenlon N; Wright N; Lew C; Stavroudis TA; Wee CP; Davidson Ward SL; Bansal M
    Pediatr Pulmonol; 2021 Jan; 56(1):88-96. PubMed ID: 33107696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Gentle SJ; Rysavy MA; Li L; Laughon MM; Patel RM; Jensen EA; Hintz S; Ambalavanan N; Carlo WA; Watterberg K;
    JAMA Netw Open; 2023 May; 6(5):e2315315. PubMed ID: 37256621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental impairment at 2 years of age in children born before 29 weeks' gestation with bronchopulmonary dysplasia.
    Decollogne L; Epiard C; Chevallier M; Ego A; Alin L; Debillon T
    Arch Pediatr; 2021 Jan; 28(1):23-28. PubMed ID: 33257210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchopulmonary dysplasia precursors influence risk of white matter injury and adverse neurodevelopmental outcome in preterm infants.
    Grelli KN; Keller RL; Rogers EE; Partridge JC; Xu D; Barkovich AJ; Gano D
    Pediatr Res; 2021 Aug; 90(2):359-365. PubMed ID: 32937647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.